Researchers at UC San Diego's Center for Wearable Sensors have developed a flexible biosensor patch that simultaneously monitors 12 key health biomarkers through sweat analysis — without any needles, blood draws, or finger pricks. The device, described in Science Translational Medicine, could transform management of diabetes, cardiovascular disease, and stress-related conditions.
The Technology
The patch, roughly the size of a credit card, adheres to the skin and uses a network of enzymatic electrochemical sensors embedded in a flexible polymer substrate to analyze sweat composition in real time. Data is transmitted wirelessly to a smartphone app every 15 minutes.
Biomarkers currently monitored include:
- Glucose (critical for diabetes management)
- Cortisol (stress and adrenal function)
- Lactate (exercise intensity and cardiac health)
- Uric acid (gout risk)
- Electrolytes (sodium, potassium, chloride, magnesium)
- pH and temperature
- Creatinine (kidney function proxy)
- Interleukin-6 (inflammation)
Clinical Validation
In a 200-person trial, the patch's glucose readings correlated with laboratory venous blood draws at r=0.97, comparable to the most accurate continuous glucose monitors currently on the market — but without the need for subcutaneous implantation.
"Continuous, non-invasive multi-biomarker monitoring is the holy grail of wearable health technology. This is the first device to do it reliably at a level clinically relevant enough to inform real treatment decisions." — Prof. Joseph Wang, UCSD
Availability
The device is expected to enter Phase II clinical trials in early 2026 with a consumer-facing version targeting the sports performance and chronic disease management markets. Early projections suggest a manufacturing cost under $8 per patch at scale.
